3.1.4.46	Coinfection	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28162921&form=6&db=m	The first case of imported Borrelia miyamotoi disease concurrent with Lyme disease.	diagnostic usage,ongoing research,therapeutic application,unassigned	1,3,1,0	
3.1.4.46	Colonic Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32095326&form=6&db=m	Glycerophosphodiester phosphodiesterase 1 (GDE1) acts as a potential tumor suppressor and is a novel therapeutic target for non-mucin-producing colon adenocarcinoma.	causal interaction,therapeutic application,unassigned	4,4,0	
3.1.4.46	Infections	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16729949&form=6&db=m	Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene.	diagnostic usage,ongoing research,unassigned	4,4,0	
3.1.4.46	Infections	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25422269&form=6&db=m	Impact of the glpQ2 gene on virulence in a Streptococcus pneumoniae serotype 19A sequence type 320 strain.	causal interaction,ongoing research,therapeutic application,unassigned	2,2,1,0	
3.1.4.46	Infections	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33255178&form=6&db=m	Glycerophosphodiester Phosphodiesterase Identified as Non-Reliable Serological Marker for Borrelia miyamotoi Disease.	diagnostic usage,therapeutic application,unassigned	2,3,0	
3.1.4.46	Lyme Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27574731&form=6&db=m	Occurrence of Borrelia burgdorferi Sensu Lato in Ixodes ricinus Ticks with First Identification of Borrelia miyamotoi in Vojvodina, Serbia.	unassigned	-	
3.1.4.46	Lyme Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30057339&form=6&db=m	Case control study: Serological evidence that Borrelia miyamotoi disease occurs nationwide in Japan.	diagnostic usage,ongoing research,unassigned	3,2,0	
3.1.4.46	Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32095326&form=6&db=m	Glycerophosphodiester phosphodiesterase 1 (GDE1) acts as a potential tumor suppressor and is a novel therapeutic target for non-mucin-producing colon adenocarcinoma.	causal interaction,therapeutic application,unassigned	4,4,0	
3.1.4.46	Neuroblastoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17275818&form=6&db=m	Involvement of membrane protein GDE2 in retinoic acid-induced neurite formation in Neuro2A cells.	causal interaction,unassigned	3,0	
3.1.4.46	Otitis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7927765&form=6&db=m	Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model.	ongoing research,unassigned	4,0